Stay updated on Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:47:53.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, signaling restricted access to this ClinicalTrials.gov record. The additions reflect the error page structure (doctype, meta, 403 title) and footer information showing the site revision.
    Difference
    19%
    Check dated 2026-09-21T22:17:35.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.6, indicating a small platform-level update. It does not change trial details, eligibility criteria, outcomes, or other substantive content on the study page.
    Difference
    0.1%
    Check dated 2026-08-31T18:28:45.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study's external identifiers now include an NIH funding reference for 2017, adding funding attribution to the record.
    Difference
    0.1%
    Check dated 2026-08-24T19:10:51.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page now displays a new revision version (v3.6.5) replacing the previous one, indicating a release update. This update pertains to the site's software layer rather than the clinical trial data or public text.
    Difference
    0.1%
    Check dated 2026-08-10T12:43:58.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page now shows a new revision tag 'Revision: v3.6.4' replacing the previous 'Revision: v3.6.3'. This indicates a minor update to the study record page's metadata rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-07-27T06:19:18.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.